BioNtech will report financial tomorrow morning. Based on previous financial data, news, future business ventures and previous quarter results, do you feel that this stock will be increasing or decreasing in value after earning results

BioNTech's stock is likely to face volatility following the earnings release, with a potential for both upward and downward movements. Here's an analysis based on relevant financial data, news, future business ventures, and previous quarter results:

1. Recent Financial Performance: BioNTech reported a net loss of €315.1 million and a diluted EPS of €-1.31 for the first quarter of 2024. The company's net income year-on-year growth rate was -162.28%, and the total revenue year-on-year growth rate was -85.42%. These figures indicate a challenging financial period.
2. Earnings Expectations: Analysts forecast an EPS of €-2.20 for the upcoming quarter, suggesting that the company's financial struggles may continue. However, the consensus EPS estimates have been upgraded to €1.74 loss, which could imply some improvement.
3. Short-term Sentiment and Trading Volume: The short-term sentiment rating is neutral, with a slight increase in trading volume. This suggests that investors are cautiously watching the stock.
4. Technical Indicators: The stock's 10-day moving average is $84.76, and the resistance level is $83.31. The closing price on August 2 was $82.01, indicating that the stock is trading below its moving average and resistance level. This typically suggests a bearish trend.

5. Future Business Ventures: BioNTech is predicting a return to revenue growth in 2025 and is developing a variant-adapted COVID-19 vaccine and accelerating clinical development activities in oncology. These future prospects could positively impact the stock price over the long term.
6. Analyst Ratings and Price Targets: The average price target from analysts is $110.86, with a range of forecasts from $83.31 to $125.83. This suggests that there is significant variation in analysts' expectations, which could lead to increased volatility after the earnings release.
7. Market Conditions: The broader market conditions, including geopolitical events and industry trends, will also influence BioNTech's stock price.

In conclusion, while BioNTech's future business ventures hold potential, the recent financial performance and the forecasted earnings decline may lead to short-term volatility. The stock's technical indicators suggest a bearish trend, but the analyst price targets indicate a potential for growth. Investors should monitor the earnings release and the company's guidance for future business strategies closely.